We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

4200:TADAWULAldrees Petroleum & Transport Services Co. Analysis

Data as of 2026-09-01 - not real-time

SAR 119.10

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Aldrees Petroleum and Transport Services Company is priced at SAR 119.10, and its moving averages give no clean directional read — the structure is neutral. It has gained 4.4% over the past 30 days. Momentum indicators put RSI at 52.9 (neutral) with MACD reading bearish. Price has been bracketed by support at SAR 116.20 and resistance at SAR 122.00.
On valuation the read is overvalued — an earnings multiple of 26.1, absent a reliable peer benchmark. Analyst price targets sit 13.1% above the current price. Revenue is growing at 18.0% on a 1.6% profit margin. The 1.70% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 5 — moderate. With 30-day volatility of 21.5%, a beta of -0.15 and a maximum drawdown of 30.0%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Near-term and long-term part ways here — sell short-term against hold longer out, with 3/10 conviction on the long call.

Top Market Events

Aldrees Petroleum and Transport Services Co.Aldrees Petroleum and Transport Services Co.Aldrees Petroleum and Transport Services Co.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 4/10

Key Factors

  • Trading below the 200-day average of 121.24
  • MACD momentum is negative
  • Maximum drawdown of 30.0%

Medium Term

1–3 years
Cautious
Model confidence: 4/10

Key Factors

  • Trading below the 200-day average of 121.24
  • Analyst targets imply +13.1% versus the current price
  • MACD momentum is negative

Long Term

> 3 years
Neutral
Model confidence: 3/10

Key Factors

  • Analyst targets imply +13.1% versus the current price
  • Revenue growth of +18.0%
  • P/E ratio of 26.1

Key Metrics & Analysis

Financial Health

Revenue Growth18.00%
Profit Margin1.64%
P/E Ratio26.1
ROE28.21%
ROA4.12%
Debt/Equity278.61
P/B Ratio7.0
Op. Cash FlowSAR1.1B
Free Cash FlowSAR468.8M

Technical Analysis

TrendNeutral
RSI52.9
SupportSAR 116.20
ResistanceSAR 122.00
MA 20SAR 119.26
MA 50SAR 116.15
MA 200SAR 121.24
MACDBearish
VolumeDecreasing
Fear & Greed Index93.11

Valuation

Fair ValueSAR 79.62
Target PriceSAR 134.76
Upside/Downside13.15%
GradeOvervalued
TypeGrowth
Dividend Yield1.70%

Risk Assessment

Beta-0.15
Volatility21.51%
Sector RiskHigh
Reg. RiskLow
Geo RiskMedium
Currency RiskHigh
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.